PATENT CLAIM ANALYSIS

Application Number: 16123703
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing, treating or delaying an Alzheimer's disease (AD) or dementia including a G protein-coupled receptor19 (GPCR19) agonist or its pharmaceutically acceptable salt as an active ingredient and a food composition for preventing, treating or delaying an Alzheimer's disease or dementia. The GPCR19 agonist according to the present invention has an effect of improving cognitive and behavioral disorders without harming the health of objects when administrated to the objects and has an effect of preventing the Alzheimer's disease or dementia or delaying or treating the progression of the disease in the objects with the disease by suppressing apoptosis of the brain tissue, enhancing immunity, and reducing formation of an amyloid β (Aβ) plague.

Claim (Index 21):
The method for treating Alzheimer's-related disease or dementia-related disease according to  claim 17 , wherein the GPCR19 agonist or its pharmaceutically acceptable salt is administrated with a dose of 10 mg/kg/day to 100 mg/kg/day.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.97101
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15516317', '15461086', '15046486', '14479614', '13706907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7372613849408561
- 35 USC 102 Novelty (BERT): 0.6583536655259337
- Combined Prediction Score: 0.7293706129993639
- Mean Citation Score: 350.313804
- Max Citation Score: 641.2294
- Similarity Product: 592.6149229195119

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test